 | • レポートコード：GIR-107A12219 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、82ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、拡張型心筋症のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。拡張型心筋症の種類別市場規模（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシンII受容体拮抗薬（ARB）、ベータ遮断薬、抗凝血薬、強心配糖体）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・拡張型心筋症の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Zensun、Capricor Therapeutics、Vericel、t2cure GmbH、MyoKardia、Kasiak Research ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシンII受容体拮抗薬（ARB）、ベータ遮断薬、抗凝血薬、強心配糖体 ・用途別分析2016年-2026年：病院、クリニック、その他 ・拡張型心筋症の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・拡張型心筋症のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・拡張型心筋症のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・拡張型心筋症の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・拡張型心筋症の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Dilated Cardiomyopathy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Dilated Cardiomyopathy size is estimated to be USD 224 million in 2026 from USD 174.7 million in 2020, with a change XX% between 2020 and 2021. The global Dilated Cardiomyopathy market size is expected to grow at a CAGR of 6.4% for the next five years.
Market segmentation
Dilated Cardiomyopathy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Diuretics
Angiotensin-Converting Enzyme (ACE) Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Beta Blockers
Blood Thinning Medications
Cardiac Glycosides
Market segment by Application, can be divided into
Hospital
Clinic
Others
Market segment by players, this report covers
Zensun
Capricor Therapeutics
Vericel
t2cure GmbH
MyoKardia
Kasiak Research
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Dilated Cardiomyopathy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Dilated Cardiomyopathy, with revenue, gross margin and global market share of Dilated Cardiomyopathy from 2019 to 2021.
Chapter 3, the Dilated Cardiomyopathy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Dilated Cardiomyopathy market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Dilated Cardiomyopathy research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Dilated Cardiomyopathy
1.2 Classification of Dilated Cardiomyopathy by Type
1.2.1 Overview: Global Dilated Cardiomyopathy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Dilated Cardiomyopathy Revenue Market Share by Type in 2020
1.2.3 Diuretics
1.2.4 Angiotensin-Converting Enzyme (ACE) Inhibitors
1.2.5 Angiotensin II Receptor Blockers (ARBs)
1.2.6 Beta Blockers
1.2.7 Blood Thinning Medications
1.2.8 Cardiac Glycosides
1.3 Global Dilated Cardiomyopathy Market by Application
1.3.1 Overview: Global Dilated Cardiomyopathy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Dilated Cardiomyopathy Market Size & Forecast
1.5 Global Dilated Cardiomyopathy Market Size and Forecast by Region
1.5.1 Global Dilated Cardiomyopathy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Dilated Cardiomyopathy Market Size by Region, (2016-2021)
1.5.3 North America Dilated Cardiomyopathy Market Size and Prospect (2016-2026)
1.5.4 Europe Dilated Cardiomyopathy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Dilated Cardiomyopathy Market Size and Prospect (2016-2026)
1.5.6 South America Dilated Cardiomyopathy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Dilated Cardiomyopathy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Dilated Cardiomyopathy Market Drivers
1.6.2 Dilated Cardiomyopathy Market Restraints
1.6.3 Dilated Cardiomyopathy Trends Analysis
2 Company Profiles
2.1 Zensun
2.1.1 Zensun Details
2.1.2 Zensun Major Business
2.1.3 Zensun Dilated Cardiomyopathy Product and Solutions
2.1.4 Zensun Dilated Cardiomyopathy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Zensun Recent Developments and Future Plans
2.2 Capricor Therapeutics
2.2.1 Capricor Therapeutics Details
2.2.2 Capricor Therapeutics Major Business
2.2.3 Capricor Therapeutics Dilated Cardiomyopathy Product and Solutions
2.2.4 Capricor Therapeutics Dilated Cardiomyopathy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Capricor Therapeutics Recent Developments and Future Plans
2.3 Vericel
2.3.1 Vericel Details
2.3.2 Vericel Major Business
2.3.3 Vericel Dilated Cardiomyopathy Product and Solutions
2.3.4 Vericel Dilated Cardiomyopathy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Vericel Recent Developments and Future Plans
2.4 t2cure GmbH
2.4.1 t2cure GmbH Details
2.4.2 t2cure GmbH Major Business
2.4.3 t2cure GmbH Dilated Cardiomyopathy Product and Solutions
2.4.4 t2cure GmbH Dilated Cardiomyopathy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 t2cure GmbH Recent Developments and Future Plans
2.5 MyoKardia
2.5.1 MyoKardia Details
2.5.2 MyoKardia Major Business
2.5.3 MyoKardia Dilated Cardiomyopathy Product and Solutions
2.5.4 MyoKardia Dilated Cardiomyopathy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 MyoKardia Recent Developments and Future Plans
2.6 Kasiak Research
2.6.1 Kasiak Research Details
2.6.2 Kasiak Research Major Business
2.6.3 Kasiak Research Dilated Cardiomyopathy Product and Solutions
2.6.4 Kasiak Research Dilated Cardiomyopathy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Kasiak Research Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Dilated Cardiomyopathy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Dilated Cardiomyopathy Players Market Share
3.2.2 Top 10 Dilated Cardiomyopathy Players Market Share
3.2.3 Market Competition Trend
3.3 Dilated Cardiomyopathy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Dilated Cardiomyopathy Revenue and Market Share by Type (2016-2021)
4.2 Global Dilated Cardiomyopathy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Dilated Cardiomyopathy Revenue Market Share by Application (2016-2021)
5.2 Dilated Cardiomyopathy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Dilated Cardiomyopathy Revenue by Type (2016-2026)
6.2 North America Dilated Cardiomyopathy Revenue by Application (2016-2026)
6.3 North America Dilated Cardiomyopathy Market Size by Country
6.3.1 North America Dilated Cardiomyopathy Revenue by Country (2016-2026)
6.3.2 United States Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
6.3.3 Canada Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
6.3.4 Mexico Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Dilated Cardiomyopathy Revenue by Type (2016-2026)
7.2 Europe Dilated Cardiomyopathy Revenue by Application (2016-2026)
7.3 Europe Dilated Cardiomyopathy Market Size by Country
7.3.1 Europe Dilated Cardiomyopathy Revenue by Country (2016-2026)
7.3.2 Germany Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
7.3.3 France Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
7.3.5 Russia Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
7.3.6 Italy Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Dilated Cardiomyopathy Revenue by Type (2016-2026)
8.2 Asia-Pacific Dilated Cardiomyopathy Revenue by Application (2016-2026)
8.3 Asia-Pacific Dilated Cardiomyopathy Market Size by Region
8.3.1 Asia-Pacific Dilated Cardiomyopathy Revenue by Region (2016-2026)
8.3.2 China Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
8.3.3 Japan Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
8.3.4 South Korea Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
8.3.5 India Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
8.3.7 Australia Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Dilated Cardiomyopathy Revenue by Type (2016-2026)
9.2 South America Dilated Cardiomyopathy Revenue by Application (2016-2026)
9.3 South America Dilated Cardiomyopathy Market Size by Country
9.3.1 South America Dilated Cardiomyopathy Revenue by Country (2016-2026)
9.3.2 Brazil Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
9.3.3 Argentina Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Dilated Cardiomyopathy Revenue by Type (2016-2026)
10.2 Middle East & Africa Dilated Cardiomyopathy Revenue by Application (2016-2026)
10.3 Middle East & Africa Dilated Cardiomyopathy Market Size by Country
10.3.1 Middle East & Africa Dilated Cardiomyopathy Revenue by Country (2016-2026)
10.3.2 Turkey Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
10.3.4 UAE Dilated Cardiomyopathy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Dilated Cardiomyopathy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Dilated Cardiomyopathy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Dilated Cardiomyopathy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Dilated Cardiomyopathy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Dilated Cardiomyopathy Revenue Market Share by Region (2021-2026)
Table 6. Zensun Corporate Information, Head Office, and Major Competitors
Table 7. Zensun Major Business
Table 8. Zensun Dilated Cardiomyopathy Product and Solutions
Table 9. Zensun Dilated Cardiomyopathy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Capricor Therapeutics Corporate Information, Head Office, and Major Competitors
Table 11. Capricor Therapeutics Major Business
Table 12. Capricor Therapeutics Dilated Cardiomyopathy Product and Solutions
Table 13. Capricor Therapeutics Dilated Cardiomyopathy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Vericel Corporate Information, Head Office, and Major Competitors
Table 15. Vericel Major Business
Table 16. Vericel Dilated Cardiomyopathy Product and Solutions
Table 17. Vericel Dilated Cardiomyopathy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. t2cure GmbH Corporate Information, Head Office, and Major Competitors
Table 19. t2cure GmbH Major Business
Table 20. t2cure GmbH Dilated Cardiomyopathy Product and Solutions
Table 21. t2cure GmbH Dilated Cardiomyopathy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. MyoKardia Corporate Information, Head Office, and Major Competitors
Table 23. MyoKardia Major Business
Table 24. MyoKardia Dilated Cardiomyopathy Product and Solutions
Table 25. MyoKardia Dilated Cardiomyopathy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Kasiak Research Corporate Information, Head Office, and Major Competitors
Table 27. Kasiak Research Major Business
Table 28. Kasiak Research Dilated Cardiomyopathy Product and Solutions
Table 29. Kasiak Research Dilated Cardiomyopathy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Dilated Cardiomyopathy Revenue (USD Million) by Players (2019-2021)
Table 31. Global Dilated Cardiomyopathy Revenue Share by Players (2019-2021)
Table 32. Breakdown of Dilated Cardiomyopathy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Dilated Cardiomyopathy Players Head Office, Products and Services Provided
Table 34. Dilated Cardiomyopathy Mergers & Acquisitions in the Past Five Years
Table 35. Dilated Cardiomyopathy New Entrants and Expansion Plans
Table 36. Global Dilated Cardiomyopathy Revenue (USD Million) by Type (2016-2021)
Table 37. Global Dilated Cardiomyopathy Revenue Share by Type (2016-2021)
Table 38. Global Dilated Cardiomyopathy Revenue Forecast by Type (2021-2026)
Table 39. Global Dilated Cardiomyopathy Revenue by Application (2016-2021)
Table 40. Global Dilated Cardiomyopathy Revenue Forecast by Application (2021-2026)
Table 41. North America Dilated Cardiomyopathy Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Dilated Cardiomyopathy Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Dilated Cardiomyopathy Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Dilated Cardiomyopathy Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Dilated Cardiomyopathy Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Dilated Cardiomyopathy Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Dilated Cardiomyopathy Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Dilated Cardiomyopathy Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Dilated Cardiomyopathy Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Dilated Cardiomyopathy Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Dilated Cardiomyopathy Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Dilated Cardiomyopathy Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Dilated Cardiomyopathy Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Dilated Cardiomyopathy Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Dilated Cardiomyopathy Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Dilated Cardiomyopathy Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Dilated Cardiomyopathy Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Dilated Cardiomyopathy Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Dilated Cardiomyopathy Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Dilated Cardiomyopathy Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Dilated Cardiomyopathy Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Dilated Cardiomyopathy Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Dilated Cardiomyopathy Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Dilated Cardiomyopathy Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Dilated Cardiomyopathy Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Dilated Cardiomyopathy Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Dilated Cardiomyopathy Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Dilated Cardiomyopathy Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Dilated Cardiomyopathy Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Dilated Cardiomyopathy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Dilated Cardiomyopathy Picture
Figure 2. Global Dilated Cardiomyopathy Revenue Market Share by Type in 2020
Figure 3. Diuretics
Figure 4. Angiotensin-Converting Enzyme (ACE) Inhibitors
Figure 5. Angiotensin II Receptor Blockers (ARBs)
Figure 6. Beta Blockers
Figure 7. Blood Thinning Medications
Figure 8. Cardiac Glycosides
Figure 9. Dilated Cardiomyopathy Revenue Market Share by Application in 2020
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Others Picture
Figure 13. Global Dilated Cardiomyopathy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Dilated Cardiomyopathy Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Dilated Cardiomyopathy Revenue Market Share by Region (2016-2026)
Figure 16. Global Dilated Cardiomyopathy Revenue Market Share by Region in 2020
Figure 17. North America Dilated Cardiomyopathy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Dilated Cardiomyopathy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Dilated Cardiomyopathy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Dilated Cardiomyopathy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Dilated Cardiomyopathy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Dilated Cardiomyopathy Market Drivers
Figure 23. Dilated Cardiomyopathy Market Restraints
Figure 24. Dilated Cardiomyopathy Market Trends
Figure 25. Zensun Recent Developments and Future Plans
Figure 26. Capricor Therapeutics Recent Developments and Future Plans
Figure 27. Vericel Recent Developments and Future Plans
Figure 28. t2cure GmbH Recent Developments and Future Plans
Figure 29. MyoKardia Recent Developments and Future Plans
Figure 30. Kasiak Research Recent Developments and Future Plans
Figure 31. Global Dilated Cardiomyopathy Revenue Share by Players in 2020
Figure 32. Dilated Cardiomyopathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Dilated Cardiomyopathy Revenue Market Share in 2020
Figure 34. Global Top 10 Players Dilated Cardiomyopathy Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Dilated Cardiomyopathy Revenue Share by Type in 2020
Figure 37. Global Dilated Cardiomyopathy Market Share Forecast by Type (2021-2026)
Figure 38. Global Dilated Cardiomyopathy Revenue Share by Application in 2020
Figure 39. Global Dilated Cardiomyopathy Market Share Forecast by Application (2021-2026)
Figure 40. North America Dilated Cardiomyopathy Sales Market Share by Type (2016-2026)
Figure 41. North America Dilated Cardiomyopathy Sales Market Share by Application (2016-2026)
Figure 42. North America Dilated Cardiomyopathy Revenue Market Share by Country (2016-2026)
Figure 43. United States Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Dilated Cardiomyopathy Sales Market Share by Type (2016-2026)
Figure 47. Europe Dilated Cardiomyopathy Sales Market Share by Application (2016-2026)
Figure 48. Europe Dilated Cardiomyopathy Revenue Market Share by Country (2016-2026)
Figure 49. Germany Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Dilated Cardiomyopathy Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Dilated Cardiomyopathy Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Dilated Cardiomyopathy Revenue Market Share by Region (2016-2026)
Figure 57. China Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Dilated Cardiomyopathy Sales Market Share by Type (2016-2026)
Figure 64. South America Dilated Cardiomyopathy Sales Market Share by Application (2016-2026)
Figure 65. South America Dilated Cardiomyopathy Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Dilated Cardiomyopathy Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Dilated Cardiomyopathy Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Dilated Cardiomyopathy Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Dilated Cardiomyopathy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
拡張型心筋症治療薬の世界市場 2019年版：種類別（アルドステロン拮抗薬、アンジオテンシン変換酵素（ACE）阻害剤、アンジオテンシンII受容体遮断薬（ARB）、ベータ遮断薬）、用途別（病院、学術機関） Scope of the Report: The global Dilated Cardiomyopathy Therapeutic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially …- 拡張型心筋症治療薬の世界市場 2019年版：種類別（薬物クラス、埋め込み型デバイス、パイプライン分析）、用途別（病院、診療所、その他） Scope of the Report: The global Dilated Cardiomyopathy Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…
- 心筋症市場：世界及び中国市場分析・予測（～2024年） Cardiomyopathy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cardiomyopathy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cardiomyopathy manufacturers and is a va…
- 世界のアンジオテンシンII受容体市場 2021：企業別、地域別、種類・用途別 The Angiotensin II Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界のアンジオテンシンII受容体拮抗薬用非ペプチド薬市場 2021：企業別、地域別、種類・用途別 The Non-Peptide Drugs of Angiotensin II Receptor Antagonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…